上集講述了PD1/PDL1在醫治癌細胞免疫治療方面的重要性，接下來我們將會繼續深入探討問題。1348Please respect copyright.ＰＥＮＡＮＡFlARsgr9k0
1348Please respect copyright.ＰＥＮＡＮＡCpSSflcjll
上集：https://www.penana.com/article/4711251348Please respect copyright.ＰＥＮＡＮＡXSXhcJAqQP
1348Please respect copyright.ＰＥＮＡＮＡgZIFVK2Kja
1348Please respect copyright.ＰＥＮＡＮＡeMx5Ij3WVl
1348Please respect copyright.ＰＥＮＡＮＡrEGer8dmWJ
（圖1）雖然阻擋PD1/PDL1可以增強T cell辨認癌細胞的能力，但另一個重要的問題是，如何確保有足夠的T cell殺滅癌細胞呢?1348Please respect copyright.ＰＥＮＡＮＡRvtAtA1JgG
1348Please respect copyright.ＰＥＮＡＮＡLJfGpbXKgA
就算成功糾正免疫系統細胞懂得把癌細胞辨認為外來之物，但免疫系統細胞數量不足的話，依然是不會達到重大效果的。1348Please respect copyright.ＰＥＮＡＮＡOpCZ9fqbgY
1348Please respect copyright.ＰＥＮＡＮＡpZZXaFBuBH
換句話說，我們需要一道能夠提升針對癌細胞的T cell數量手段。1348Please respect copyright.ＰＥＮＡＮＡMIecBBZ9Cq
1348Please respect copyright.ＰＥＮＡＮＡmMLwOZ4BOV
1348Please respect copyright.ＰＥＮＡＮＡjPLPK6JP9a
1348Please respect copyright.ＰＥＮＡＮＡihKc1vSg6B
（圖2）T cell的產生數量，接近可以說是由Antigen Presenting Cells(APC)來決定;1348Please respect copyright.ＰＥＮＡＮＡq3y7FXIxwS
APC可以睇成為一堆負責把癌細胞獨特Neoantigen帶來T cell面前的細胞。1348Please respect copyright.ＰＥＮＡＮＡ7rHGVXhoCo
1348Please respect copyright.ＰＥＮＡＮＡlsnllTYXMb
忘記甚麼是Neoantigen的話，可重溫上一集。1348Please respect copyright.ＰＥＮＡＮＡTF8LIZBsr1
1348Please respect copyright.ＰＥＮＡＮＡUfWXIDjNRD
當APC展示癌細胞的Neoantigen予T cell的receptor後，另一個必需的動作就是T cell表面的CD28與APC表面的B7合併。1348Please respect copyright.ＰＥＮＡＮＡ16P2AsuJVM
1348Please respect copyright.ＰＥＮＡＮＡh3oCkHOhaQ
只要兩者條件達成的話，負責對付對應癌細胞的T cell數量及效力便會大增。1348Please respect copyright.ＰＥＮＡＮＡnCPRIX0rfX
1348Please respect copyright.ＰＥＮＡＮＡxRAPnrQDuR
1348Please respect copyright.ＰＥＮＡＮＡmGKsbd8oxi
1348Please respect copyright.ＰＥＮＡＮＡJ9v0EffdDS
（圖3）然而，當T cell數量產生至一定程度的時候，T cell便會產生出CTLA4。CTLA4會搶奪CD28的位置，與B7合併。1348Please respect copyright.ＰＥＮＡＮＡbJOZbK9DZQ
1348Please respect copyright.ＰＥＮＡＮＡyNqcZeBsN2
而當CTLA4與B7合併後，T cell所產生的數量及威力就會大減。1348Please respect copyright.ＰＥＮＡＮＡsjIjt0e2Xo
1348Please respect copyright.ＰＥＮＡＮＡRZCPFYaAAG
這個CTLA4產生的機制是與生俱來的，目的就是為了避免產生過量的T cell，以免身體會產生不良反應。1348Please respect copyright.ＰＥＮＡＮＡkPFI5jW9EH
1348Please respect copyright.ＰＥＮＡＮＡTD7IrIrWqB
1348Please respect copyright.ＰＥＮＡＮＡ4VK6DVaKBk
（圖4）只不過的是，現時癌細胞大敵當前，燃眉之急就是要調動大量的T cell前往討伐癌細胞。1348Please respect copyright.ＰＥＮＡＮＡVcwa9OZrvA
1348Please respect copyright.ＰＥＮＡＮＡjfa8Tn5k77
為此，我們重施應對PD1/PDL1故技，利用抗體阻擋CTLA4，確保CD28及B7持續合併，不斷產生效力高強的T cell。1348Please respect copyright.ＰＥＮＡＮＡ0IDR2OPbrA
1348Please respect copyright.ＰＥＮＡＮＡo8O7I6eeHo
1348Please respect copyright.ＰＥＮＡＮＡMUOKtIvmNF
（圖5）簡略的總結來說，為了確保有足夠的T cell消滅癌細胞，我們不惜採用阻擋CTLA4的抗體，號令身體持續產生效力高強的T cell。1348Please respect copyright.ＰＥＮＡＮＡ9SOaNS9pRW
而另一邊廂，我們亦同時利用阻擋PD1/PDL1的抗體，確保T cell能夠順利把癌細胞辨認成為外來物，將其制裁。1348Please respect copyright.ＰＥＮＡＮＡJqu6uagcrx
1348Please respect copyright.ＰＥＮＡＮＡe4UnJ5zVY5
這CTLA4抗體及PD1/PDL1抗體的雙管齊下療法，將能大大提升免疫治療的效率。1348Please respect copyright.ＰＥＮＡＮＡndXmsdldSQ
1348Please respect copyright.ＰＥＮＡＮＡFMoaxLphVL
但是，並不是所有病人也能依靠這方法而得益，原因是T cell沒法能夠順利抵達癌細胞的位置以及滲入癌細胞的內部作有效的消滅。1348Please respect copyright.ＰＥＮＡＮＡxiI4fZ8G5G
1348Please respect copyright.ＰＥＮＡＮＡxFhPPWf3ye
這一方面，我們將會在下一篇免疫治療的最終章再作探討。1348Please respect copyright.ＰＥＮＡＮＡLV4H1SuCkB
1348Please respect copyright.ＰＥＮＡＮＡ1gxew4sG5e
1348Please respect copyright.ＰＥＮＡＮＡ8cFx3EHmdk
如果想我快啲出文的話，請入去Penana網站科普專欄–薯不揀單俾一個like以及Bookmark，這對我非常之重要。1348Please respect copyright.ＰＥＮＡＮＡ9WebG0LSk2
1348Please respect copyright.ＰＥＮＡＮＡbGJKiDJbgT
Link: https://www.penana.com/story/66244/%E7%A7%91%E6%99%AE%E5%B0%88%E6%AC%84-%E8%96%AF%E4%B8%8D%E6%8F%80%E5%96%AE/toc1348Please respect copyright.ＰＥＮＡＮＡCv4tM1Cnll
1348Please respect copyright.ＰＥＮＡＮＡoUiF4WeB5k
同時亦可以在Penana網站裡按「買一嚿/半嚿薯仔」，以課金的方式推動我繼續搜羅資料寫文，多謝。1348Please respect copyright.ＰＥＮＡＮＡHmL0EQRXHY
1348Please respect copyright.ＰＥＮＡＮＡ2m4EVvxddJ
Link:1348Please respect copyright.ＰＥＮＡＮＡVRPFQnAugC
https://www.penana.com/user/27349/%E8%96%AF%E4%BB%94%E8%81%9E%E8%8C%B1%E8%8E%89/portfolio1348Please respect copyright.ＰＥＮＡＮＡa0CwJvQUjs
1348Please respect copyright.ＰＥＮＡＮＡo6cLhDfywW
1348Please respect copyright.ＰＥＮＡＮＡeeyn45NyIY
有興趣接收科普資訊的話，歡迎follow IG: potatopigtongue。1348Please respect copyright.ＰＥＮＡＮＡBtUQpvyhPJ
Penana
search
登入arrow_drop_down
註冊arrow_drop_down
